688212 澳华内镜
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-4.2961.5304.3701.722--
总资产报酬率 ROA (%)-3.1381.2573.7871.542--
投入资产回报率 ROIC (%)-3.5111.4104.2151.673--

边际利润分析
销售毛利率 (%)60.51268.12469.73869.725--
营业利润率 (%)-19.9190.9408.0142.553--
息税前利润/营业总收入 (%)-19.7270.8687.5622.424--
净利润/营业总收入 (%)-13.2282.7118.9635.626--

收益指标分析
经营活动净收益/利润总额(%)115.514-271.80748.7791.151--
价值变动净收益/利润总额(%)-0.212159.36021.41281.591--
营业外收支净额/利润总额(%)0.260-9.607-0.79633.083--

偿债能力分析
流动比率 (X)2.1323.5187.1097.81016.902
速动比率 (X)1.5732.7035.7016.43215.253
资产负债率 (%)31.01421.05612.53212.2236.697
带息债务/全部投入资本 (%)19.0186.264-0.457-0.159-0.242
股东权益/带息债务 (%)397.8591,407.790-21,098.455-60,708.664-40,419.499
股东权益/负债合计 (%)219.852371.012690.393710.3801,381.880
利息保障倍数 (X)-81.05480.309-19.476-1.744--

营运能力分析
应收账款周转天数 (天)186.092111.67185.06479.621--
存货周转天数 (天)388.864323.600332.882369.936--